Surrey Heartlands

Joint Formulary & PAD

Dutasteride - Benign prostatic hyperplasia

You are here : Home > Formulary Search > Dutasteride - Benign prostatic hyperplasia

I agree that in using this database I understand that this platform only provides guidance on local prescribing policy and that all prescribing decisions are ultimately the responsibility of the clinician.

Status 1

Green
Formulations :
  • Capsules
Formulary Status :
Primary Care
ASPH
RSFT
SASH
SABP
Associated Icons :
BNF SPC
Restrictions / Comments :

Documentation

  • No records returned.

PAD Profile

ChemicalSubstance :
Dutasteride
Indication :
Benign prostatic hyperplasia
Group Name :
Keywords :
BPH, LUTS, enlarged prostate, urinary frequency
Brand Names Include :
Avodart
Important Information :
Latest Additions Date From :
Latest Additions Date To :
Guidelines :
Supporting Documents :
0

Other Indications

Below are listed other indications that Dutasteride is used to treat.

  • No records returned.

Other Drugs

Below are listed other drugs that are used to treat Benign prostatic hyperplasia.

Committee Recommendations (1)

18 Dec 17 - Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)

The PCN recommends the following medicines as treatment options for the management of benign prostatic hyperplasia and has assigned the following traffic light status to each treatment option as follows -

  • Finasteride – GREEN (1st line)
  • Dutasteride – GREEN (2nd line)